rights
-
Extremities
New Orthopedic Device Technology Moves From Lab Toward Operating Room With Help From Philadelphia-Based Start-Up OrthoMend Research, Inc.
PHILADELPHIA, Dec. 9, 2016 /PRNewswire-USNewswire/ — A platform of orthopedic device technologies developed by researchers from Temple University are moving one step closer to becoming viable…
Read More » -
Financial
Xtant Medical Closes Rights Offering for Gross Proceeds of $3.8 Million
BELGRADE, Mont., Nov. 17, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
Xtant Medical Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period and Final Subscription Price
BELGRADE, Mont., Nov. 11, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
Xtant Medical Announces Adjustment to Subscription Price of Rights Offering
BELGRADE, Mont., Nov. 09, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Xtant Medical Announces Commencement of Subscription Period for Previously Announced Rights Offering
BELGRADE, Mont., Oct. 31, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
Progenerative Medical Obtains Exclusive Rights to Tissue Regeneration Technology
SAN ANTONIO, Sept. 14, 2016 /PRNewswire Progenerative Medical, Inc. (PGM), a clinical-ready medical device company announced today they have entered into a…
Read More » -
Spine
Ferring Pharmaceuticals Acquires Exclusive Licensing Rights to Condoliase from Seikagaku Corporation
August 29, 2016 03:13 AM Eastern Daylight Time SAINT PREX, Switzerland–(BUSINESS WIRE)–Ferring Pharmaceuticals announced today that it has signed an…
Read More » -
Financial
Histogenics Corporation Acquires NeoCart® Development and Commercialization Rights for Japanese Market
WALTHAM, Mass., May 10, 2016 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and…
Read More » -
Financial
Integra LifeSciences (IART) to Acquire U.S. Rights to Certain Tornier (TRNX) Assets
Integra LifeSciences (NASDAQ: IART) and Tornier N.V. (Nasdaq: TRNX), announced a definitive agreement under which Integra will acquire the United States rights…
Read More »